Base award. Non-clinical adme studies. POP: 09/19/2016 - 09/18/2021. N01DA-16-8931.

Ended Definitive Contract Awarded Last action

Contract number
HHSN271201600037C
Awardee
Awarding agency
Obligated
$489,891

Award facts

Opportunity
Contract value 13% obligated
  • $489,891.25 Current, with exercised options
  • $3,698,818.25 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 -$56,851
Funding Only Action P00007 · Purpose: the scope of this task order is for the administration of the basic contract. This does not include the administrative activities that will be… $25,458
Funding Only Action P00006 · Task order 05. Non-clinical adme studies. Task order POP: 07/10/2019-07/09/2020. N01DA-16-8931. Purpose: the scope of this task order is a) develop an… $110,249
Funding Only Action 5 · Task order 04. Non-clinical adme studies. POP: 09/19/2016 - 09/18/2021. N01DA-16-8931. Purpose: to obligate funds to fully fund performance under task order… $86,049
Funding Only Action 4 $33,913
Funding Only Action 3 · Task order 02 MOD 01. Non-clinical adme studies. POP: 09/19/2016 - 09/18/2021. N01DA-16-8931.purpose: to obligate funds to fully fund performance under task… $29,108
Supplemental Agreement for work within scope 2 · Task order 03. Non-clinical adme studies. POP: 09/19/2016 - 09/18/2021. N01DA-16-8931.purpose: to obligate funds to fully fund performance under task order 03… $63,035
Supplemental Agreement for work within scope 1 · Non-clinical adme studies. POP: 09/19/2016 - 09/18/2021. N01DA-16-8931.purpose: to obligate funds to fully fund performance under task order 02 and to modify… $27,954
Original award $170,976

About this award

This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to SRI International, a non-profit research institute. The $3,698,818.25 contract is for non-clinical absorption, distribution, metabolism, and excretion (ADME) studies, with a period of performance from September 19, 2016 to September 18, 2021. This award does not have a small business set-aside. SRI International, as the prime contractor, will be conducting this research and development work for NIDA, which is focused on advancing drug discovery and development. SRI International has extensive experience supporting biomedical research and development projects for federal agencies through both contracts and grants.

Quick answers

Who was awarded contract HHSN271201600037C?

HHSN271201600037C was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 19, 2016.

How much is contract HHSN271201600037C worth?

The government has obligated $489,891 on HHSN271201600037C. Its potential value, with all options, is $3,698,818.

Was contract HHSN271201600037C competed?

The extent of competition for HHSN271201600037C was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award